APSA strives to be the physician-scientist student's leading voice on national policies that impact their current training and future careers. The Policy Committee leads APSA by making recommendations based upon feedback, collected surveys, and literature to the leadership and the board of directors as to the future directions of APSA. This committee is critical to ensuring that APSA addresses the current needs and issues of its membership. They work closely with other organizations with common interests by providing a voice to future physician-scientists.
There are three core components forming the foundation of APSA's national advocacy on behalf of physician-scientist students: improvement of educational opportunities, advancement of patient-oriented research, and advocacy for the future of translational medicine.
Improvment of Educational Opportunities
The APSA Policy Committee improves educational opportunities for physician scientist trainees through various programs, including the creation of comprehensive databases that provide resources tailored for different levels of training, as well as research projects assessing trainee needs and best practices for education policy makers.
Advancement of Patient-Oriented Research
The APSA Policy Committee advances patient-oriented research by physician scientist trainees through the development of workshops and speaker panels that include world renowned experts to broaden the perspectives of our members and showcase to trainees the wide array of research with high societal impact.
Advocacy for the Future of Biomedical and Translational Research
The APSA Policy Committee advocates for the future of biomedical and translational research through communications with policy makers and educators via petition letters and policy statements, as well as mobilizing our members through advocacy action alerts and periodic critical announcements that keep our members informed and engaged. For example, APSA recently highlighted the mHealth conference and its focus on innovative mobile health technologies.